drugset / Trial / NCT01270724
Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)
NaSingle-groupOpen-labelTreatment
Summary
This study will look to see how well patients with relapsed or recurrent intracranial germ cell tumors respond to the new combination of chemotherapy (in induction)of Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx) followed by consolidation chemotherapy and autologous stem cell rescue.
Timeline
- Start
- 2010-08
- Primary completion
- 2019-10-23
- Completion
- 2019-12-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | — | — |
| Subject | Oxaliplatin | Small molecule | — | — |
| Subject | Paclitaxel | Small molecule | — | — |